Promis Neurosciences Inc (PMN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 924 | 1,200 | 1,844 | 3,562 | 5,275 |
| Marketable Securities | 31 | 31 | 32 | 32 | 32 |
| Receivables | 44 | 38 | 42 | 50 | 64 |
| TOTAL | $1,091 | $1,411 | $2,244 | $3,937 | $5,566 |
| Non-Current Assets | |||||
| PPE Net | 1 | 1 | 2 | 1 | 2 |
| Intangibles | 39 | 40 | 42 | 43 | 45 |
| TOTAL | $40 | $42 | $44 | $45 | $47 |
| Total Assets | $1,131 | $1,453 | $2,288 | $3,982 | $5,612 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 507 | 303 | 550 | 228 | 236 |
| Accrued Expenses | 217 | 278 | 362 | 349 | 130 |
| Other current liabilities | N/A | N/A | 485 | N/A | N/A |
| TOTAL | $724 | $582 | $1,396 | $577 | $366 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $724 | $582 | $1,396 | $577 | $366 |
| Shareholders' Equity | |||||
| Common Shares | 35,565 | 35,340 | 34,890 | 34,563 | 34,806 |
| Retained earnings | -46,727 | -45,616 | -44,893 | -41,872 | -40,140 |
| Other shareholders' equity | 5,567 | 5,109 | 4,731 | 4,598 | 4,393 |
| TOTAL | $407 | $871 | $892 | $3,405 | $5,246 |
| Total Liabilities And Equity | $1,131 | $1,453 | $2,288 | $3,982 | $5,612 |